| |
| |
|
| Insider
Information: |
Tarriff Scott |
| Relationship: |
Director |
| City: |
Mahwah |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
764,807 |
|
|
Indirect Shares
|
992,623 |
|
|
| Direct
Value |
$2,138,425 |
|
|
|
Indirect Value
|
$4,506,508 |
|
|
| Total
Shares |
1,757,430 |
|
|
| Total
Value |
$6,644,934 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -287.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director |
2011-04-12 |
0 |
2009-09-17 |
0 |
Premium* |
|
|
Eagle Pharmaceuticals, Inc. |
EGRX |
|
2024-02-28 |
460,621 |
2024-02-28 |
992,623 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director |
2015-09-25 |
4,186 |
2015-09-25 |
0 |
Premium* |
|
|
Theriva Biologics Ord Shs |
TOVX |
Director |
2016-11-18 |
300,000 |
2016-11-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EGRX |
Eagle Pharmaceuticals, In... |
|
– – • |
2024-02-28 |
4 |
D |
$6.27 |
$13,286 |
D/D |
(2,119) |
460,621 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
|
– – • |
2024-02-27 |
4 |
D |
$6.44 |
$20,312 |
D/D |
(3,154) |
462,740 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
|
– – • |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
12,950 |
465,894 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
|
– – • |
2024-01-05 |
4 |
D |
$5.13 |
$22,172 |
D/D |
(4,322) |
541,125 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2023-10-03 |
4 |
AS |
$14.41 |
$155,174 |
D/D |
(10,734) |
567,066 |
0 |
% |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2023-10-02 |
4 |
AS |
$15.23 |
$144,853 |
D/D |
(9,511) |
577,800 |
0 |
% |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2023-05-16 |
4 |
S |
$19.98 |
$299,700 |
D/D |
(15,000) |
587,311 |
0 |
% |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2023-05-15 |
4 |
S |
$21.06 |
$315,992 |
D/D |
(15,000) |
1,594,934 |
0 |
% |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2023-05-12 |
4 |
S |
$19.69 |
$304,014 |
D/D |
(15,000) |
1,609,934 |
0 |
% |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2023-05-11 |
4 |
S |
$20.71 |
$310,650 |
D/D |
(15,000) |
1,624,934 |
0 |
% |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
70,900 |
1,639,934 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2023-02-28 |
4 |
D |
$28.00 |
$87,164 |
D/D |
(3,113) |
1,569,034 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2023-01-23 |
4 |
D |
$33.64 |
$125,544 |
D/D |
(3,732) |
1,572,147 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2023-01-05 |
4 |
D |
$29.26 |
$111,978 |
D/D |
(3,827) |
1,575,879 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
34,800 |
1,579,706 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2021-01-23 |
4 |
D |
$47.70 |
$220,899 |
D/D |
(4,631) |
1,546,323 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2020-01-23 |
4 |
D |
$57.98 |
$437,633 |
D/D |
(7,548) |
1,550,954 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2020-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
58,300 |
1,558,502 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2019-04-01 |
4 |
AS |
$50.15 |
$1,252,496 |
D/D |
(24,975) |
1,500,202 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2019-03-01 |
4 |
AS |
$50.51 |
$1,250,015 |
D/D |
(24,428) |
1,525,177 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2019-02-01 |
4 |
AS |
$41.52 |
$1,249,831 |
D/D |
(30,085) |
1,549,605 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2019-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
61,300 |
1,579,690 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2019-01-03 |
4 |
AS |
$39.04 |
$651,058 |
D/D |
(16,569) |
1,518,390 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2019-01-02 |
4 |
AS |
$39.30 |
$595,705 |
D/D |
(15,000) |
1,534,959 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • – |
2018-06-28 |
4 |
OE |
$4.04 |
$504,208 |
D/D |
124,804 |
1,549,959 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
